{
  "page_id": 1,
  "metadata": {
    "file_name": "doc_0451.png",
    "image_width": 772,
    "image_height": 1000
  },
  "lines": [
    {
      "text": "RCH",
      "bbox": [
        560,
        23,
        688,
        77
      ],
      "confidence": 0.976513683795929
    },
    {
      "text": "HK02155001",
      "bbox": [
        472,
        91,
        609,
        115
      ],
      "confidence": 0.9633563756942749
    },
    {
      "text": "A New Subcutaneously-Implantable",
      "bbox": [
        134,
        112,
        595,
        149
      ],
      "confidence": 0.9913063049316406
    },
    {
      "text": "Reservoir for Sustained Release",
      "bbox": [
        160,
        149,
        568,
        182
      ],
      "confidence": 0.9887182116508484
    },
    {
      "text": "of Nicotine in the Rat'",
      "bbox": [
        219,
        182,
        508,
        217
      ],
      "confidence": 0.9888517260551453
    },
    {
      "text": "CARLTON K. ERICKSON.‡ SALOMON A. STAVCHANSKY. KATHE 1. KOCH",
      "bbox": [
        135,
        241,
        593,
        262
      ],
      "confidence": 0.9655137658119202
    },
    {
      "text": "AND JAMES W. McGINITY",
      "bbox": [
        282,
        257,
        446,
        273
      ],
      "confidence": 0.9371717572212219
    },
    {
      "text": ".",
      "bbox": [
        524,
        266,
        531,
        271
      ],
      "confidence": 0.7027318477630615
    },
    {
      "text": "Drug Dxnamics Institute. College of Phurmicy. The University of Texas. Austin. TX 78712",
      "bbox": [
        118,
        279,
        606,
        297
      ],
      "confidence": 0.9625106453895569
    },
    {
      "text": "Received 19 December 1981",
      "bbox": [
        288,
        314,
        438,
        328
      ],
      "confidence": 0.9763156771659851
    },
    {
      "text": "ERICKSON. C. K. S. A. STAVCHANSKY. K.L. KOCH AND J. W. McGINITY.A mW Mb MaMSA-iMpMbL.",
      "bbox": [
        108,
        348,
        613,
        364
      ],
      "confidence": 0.8394644260406494
    },
    {
      "text": "PSCT Jor Wsd & W of tn in thr nar. PHARMAC. BJOCHE.M. BEHAV. 172: 183-185. 192.—A",
      "bbox": [
        106,
        358,
        614,
        376
      ],
      "confidence": 0.6964914202690125
    },
    {
      "text": "subeatancousd-implantable icrvort for the ststained release of nicotine is described. The device. dubbed INR for",
      "bbox": [
        108,
        369,
        614,
        388
      ],
      "confidence": 0.6993277668952942
    },
    {
      "text": "Implantable Nicetne Reservour. is a small glass cup seated with Silastic polymer. I releuses 3.4 mg of nicotinc per 24",
      "bbox": [
        108,
        380,
        614,
        398
      ],
      "confidence": 0.8912603259086609
    },
    {
      "text": "Nicotne",
      "bbox": [
        111,
        439,
        152,
        450
      ],
      "confidence": 0.9196599125862122
    },
    {
      "text": "Sustained release",
      "bbox": [
        169,
        438,
        243,
        449
      ],
      "confidence": 0.9646966457366943
    },
    {
      "text": "Rals",
      "bbox": [
        259,
        436,
        286,
        448
      ],
      "confidence": 0.8479431867599487
    },
    {
      "text": "Body temperature",
      "bbox": [
        299,
        434,
        380,
        450
      ],
      "confidence": 0.9837923049926758
    },
    {
      "text": "Blosod levels",
      "bbox": [
        396,
        436,
        455,
        451
      ],
      "confidence": 0.9688106179237366
    },
    {
      "text": "Implunt",
      "bbox": [
        469,
        439,
        510,
        453
      ],
      "confidence": 0.9434479475021362
    },
    {
      "text": "NICOTINE., the predominant alkaloid in tobacco, has be-",
      "bbox": [
        67,
        478,
        352,
        494
      ],
      "confidence": 0.9660929441452026
    },
    {
      "text": "glass imptant with a Silastic® cap through which nicotine is",
      "bbox": [
        368,
        479,
        643,
        494
      ],
      "confidence": 0.9566992521286011
    },
    {
      "text": "comc a w idely studied drug for its pharmacological and toxi-",
      "bbox": [
        66,
        490,
        353,
        506
      ],
      "confidence": 0.9627395868301392
    },
    {
      "text": "cological effects. It may induce on exacerbate several car-",
      "bbox": [
        66,
        501,
        353,
        518
      ],
      "confidence": 0.9757291078567505
    },
    {
      "text": "slowly released.",
      "bbox": [
        369,
        492,
        448,
        505
      ],
      "confidence": 0.9685101509094238
    },
    {
      "text": "dioyavcular, respiratory. and neoplastic states in both hu-",
      "bbox": [
        67,
        513,
        352,
        529
      ],
      "confidence": 0.9491135478019714
    },
    {
      "text": "METHOD",
      "bbox": [
        490,
        517,
        529,
        528
      ],
      "confidence": 0.8752977252006531
    },
    {
      "text": "mans and laboratory animals [7. 8, 10].",
      "bbox": [
        66,
        525,
        257,
        541
      ],
      "confidence": 0.9448716640472412
    },
    {
      "text": "Muterials",
      "bbox": [
        368,
        532,
        417,
        546
      ],
      "confidence": 0.8546758890151978
    },
    {
      "text": "tion of cigarette smoke or bccally through th lining of te",
      "bbox": [
        66,
        546,
        354,
        565
      ],
      "confidence": 0.6356859803199768
    },
    {
      "text": "In humans. nicotine is normally administered by inhala-",
      "bbox": [
        81,
        535,
        352,
        552
      ],
      "confidence": 0.975256621837616
    },
    {
      "text": "The dirug and chemical sources were as follows: nicotine",
      "bbox": [
        382,
        547,
        640,
        565
      ],
      "confidence": 0.9952046275138855
    },
    {
      "text": "mouth by absorption of solubilized nicotine from chewing",
      "bbox": [
        66,
        557,
        354,
        577
      ],
      "confidence": 0.9426367878913879
    },
    {
      "text": "alkaloid. Sigma Chemical Co. (St. Louis. MOn: Silastic",
      "bbox": [
        368,
        557,
        639,
        577
      ],
      "confidence": 0.9167364835739136
    },
    {
      "text": "tobacco. Blood nicotine levels ofen remain high as the result",
      "bbox": [
        66,
        569,
        354,
        588
      ],
      "confidence": 0.892703652381897
    },
    {
      "text": "elastomer. 382 Medical Grade Elastomer mixcdi with",
      "bbox": [
        369,
        571,
        640,
        587
      ],
      "confidence": 0.9531505107879639
    },
    {
      "text": "of chain-smoking or the continual chewing of tobacco. In",
      "bbox": [
        66,
        580,
        354,
        600
      ],
      "confidence": 0.9758381247520447
    },
    {
      "text": "animals. forced-administration methods for nicotine include",
      "bbox": [
        66,
        592,
        354,
        611
      ],
      "confidence": 0.9732152223587036
    },
    {
      "text": "catalyst. Catalyst M Stannous Octoate, Dow Comning Co.",
      "bbox": [
        368,
        582,
        638,
        598
      ],
      "confidence": 0.966529130935669
    },
    {
      "text": "parenieral injection [13-16]. administration by inhalation of",
      "bbox": [
        67,
        602,
        354,
        623
      ],
      "confidence": 0.8546350002288818
    },
    {
      "text": "(Midland. Mli: N-ethy luornicotine, a gift from Dr. P. Jacobs,",
      "bbox": [
        369,
        593,
        638,
        609
      ],
      "confidence": 0.9126110076904297
    },
    {
      "text": "University of California at San Francisco.",
      "bbox": [
        369,
        604,
        563,
        620
      ],
      "confidence": 0.9742079377174377
    },
    {
      "text": "igarctte smoe 13. solbilization n drinking water 14) and",
      "bbox": [
        67,
        614,
        353,
        635
      ],
      "confidence": 0.6344218850135803
    },
    {
      "text": "injection in singic doses [2) or chronically via Alzet",
      "bbox": [
        68,
        626,
        354,
        647
      ],
      "confidence": 0.9148135185241699
    },
    {
      "text": "Animaly",
      "bbox": [
        367,
        628,
        408,
        643
      ],
      "confidence": 0.9679071307182312
    },
    {
      "text": "minipump (1) into thc ventricles of the brain. Nicotine has",
      "bbox": [
        68,
        638,
        353,
        658
      ],
      "confidence": 0.9235547184944153
    },
    {
      "text": "also been self-administered intravenously [17). The most",
      "bbox": [
        68,
        650,
        353,
        670
      ],
      "confidence": 0.9539236426353455
    },
    {
      "text": "Sixteein female SD/ARC rats (derived from Sprague Daw-",
      "bbox": [
        380,
        645,
        636,
        661
      ],
      "confidence": 0.9803543090820312
    },
    {
      "text": "comon route of forcedadministration in anmals is by par",
      "bbox": [
        68,
        661,
        352,
        683
      ],
      "confidence": 0.7387521266937256
    },
    {
      "text": "The University of Texas) were used in the experiments.",
      "bbox": [
        365,
        666,
        637,
        687
      ],
      "confidence": 0.9365318417549133
    },
    {
      "text": "ley stock. originally obtained from Chartes River and bred at",
      "bbox": [
        367,
        657,
        636,
        673
      ],
      "confidence": 0.9726915955543518
    },
    {
      "text": "enteral injectin. Ofentimes upto 6 daiy doses are given.",
      "bbox": [
        69,
        673,
        352,
        695
      ],
      "confidence": 0.6791062951087952
    },
    {
      "text": "They were housed in groups of 3-4 in wire bottomed stain-",
      "bbox": [
        365,
        678,
        636,
        698
      ],
      "confidence": 0.9238765239715576
    },
    {
      "text": "the duration of each dose being 15-120 minutes, depending",
      "bbox": [
        69,
        685,
        351,
        706
      ],
      "confidence": 0.9090679287910461
    },
    {
      "text": "less steel cages on  1/12 gh/dar cycle a Food (Lab",
      "bbox": [
        364,
        689,
        636,
        709
      ],
      "confidence": 0.6433835029602051
    },
    {
      "text": "upon the size of the dose [9.13].",
      "bbox": [
        70,
        699,
        227,
        717
      ],
      "confidence": 0.978363037109375
    },
    {
      "text": "Previous animal studies involving tolerance to nicotine or",
      "bbox": [
        85,
        709,
        349,
        728
      ],
      "confidence": 0.9759209752082825
    },
    {
      "text": "Blox. Purinad and water were available ad lib. The rats",
      "bbox": [
        364,
        701,
        636,
        721
      ],
      "confidence": 0.8993535041809082
    },
    {
      "text": "to the toxicological effects of continual exposure to nicotine",
      "bbox": [
        70,
        721,
        349,
        740
      ],
      "confidence": 0.9912437200546265
    },
    {
      "text": "weighed 200 250 g at the start of the experiment.",
      "bbox": [
        364,
        713,
        593,
        731
      ],
      "confidence": 0.9671483635902405
    },
    {
      "text": "have been hampered by the inubility of investigators to ad.",
      "bbox": [
        70,
        732,
        348,
        750
      ],
      "confidence": 0.9838674068450928
    },
    {
      "text": "Implan Marudacture",
      "bbox": [
        362,
        736,
        468,
        751
      ],
      "confidence": 0.8627410531044006
    },
    {
      "text": "minuster nicotine conveniently over long periods of time. We",
      "bbox": [
        70,
        743,
        348,
        762
      ],
      "confidence": 0.9772256016731262
    },
    {
      "text": "felt that a sustained-release form of nicotine would be useful.",
      "bbox": [
        70,
        755,
        346,
        774
      ],
      "confidence": 0.9853478670120239
    },
    {
      "text": "Preliminary (unpublished; results in our laboratory indi-",
      "bbox": [
        373,
        751,
        634,
        770
      ],
      "confidence": 0.9739956259727478
    },
    {
      "text": "in much the same manner as sustained release forms for",
      "bbox": [
        70,
        766,
        346,
        785
      ],
      "confidence": 0.9893168210983276
    },
    {
      "text": "cated that the sod nicotine biartrate dd not rele easly",
      "bbox": [
        360,
        762,
        634,
        783
      ],
      "confidence": 0.6673923134803772
    },
    {
      "text": "morphine [11]. ethanol (5.6], and amphetamine [4] have been",
      "bbox": [
        70,
        778,
        346,
        796
      ],
      "confidence": 0.9363148808479309
    },
    {
      "text": "useful for studying chronic toxicity and dependence in",
      "bbox": [
        70,
        787,
        345,
        810
      ],
      "confidence": 0.9545665383338928
    },
    {
      "text": "from a silaistic matix such s the one used for morphine 11.",
      "bbox": [
        359,
        774,
        633,
        793
      ],
      "confidence": 0.6364659667015076
    },
    {
      "text": "Therefore, we chove the liquid nicotine alkaloid for our re-",
      "bbox": [
        359,
        786,
        633,
        804
      ],
      "confidence": 0.9469457268714905
    },
    {
      "text": "animals. This paper reports the sticcessful development of a",
      "bbox": [
        71,
        800,
        345,
        819
      ],
      "confidence": 0.9455441832542419
    },
    {
      "text": "leave studics. In further tests we found that the release of",
      "bbox": [
        361,
        800,
        633,
        815
      ],
      "confidence": 0.964140772819519
    },
    {
      "text": "The wor wasppedrant  1 from The Couc for Toba RevechU.S.A. Inc Ponis of t wore porein",
      "bbox": [
        76,
        822,
        633,
        845
      ],
      "confidence": 0.6157540082931519
    },
    {
      "text": "1.JnP.= 39: 316. 1980",
      "bbox": [
        70,
        840,
        179,
        853
      ],
      "confidence": 0.6567696332931519
    },
    {
      "text": "Send reprnt requests toc Carlton K. Enckson. College of Pharmacs. The Universaty of Tevas. Austin, TX 78712.",
      "bbox": [
        78,
        843,
        547,
        863
      ],
      "confidence": 0.9435511231422424
    },
    {
      "text": "Copyright · 1982 ANKHO International Inc.--0091-3057:82/080183-03503.00/0",
      "bbox": [
        159,
        881,
        557,
        904
      ],
      "confidence": 0.9502497911453247
    }
  ],
  "full_text": "RCH\nHK02155001\nA New Subcutaneously-Implantable\nReservoir for Sustained Release\nof Nicotine in the Rat'\nCARLTON K. ERICKSON.‡ SALOMON A. STAVCHANSKY. KATHE 1. KOCH\nAND JAMES W. McGINITY\n.\nDrug Dxnamics Institute. College of Phurmicy. The University of Texas. Austin. TX 78712\nReceived 19 December 1981\nERICKSON. C. K. S. A. STAVCHANSKY. K.L. KOCH AND J. W. McGINITY.A mW Mb MaMSA-iMpMbL.\nPSCT Jor Wsd & W of tn in thr nar. PHARMAC. BJOCHE.M. BEHAV. 172: 183-185. 192.—A\nsubeatancousd-implantable icrvort for the ststained release of nicotine is described. The device. dubbed INR for\nImplantable Nicetne Reservour. is a small glass cup seated with Silastic polymer. I releuses 3.4 mg of nicotinc per 24\nNicotne\nSustained release\nRals\nBody temperature\nBlosod levels\nImplunt\nNICOTINE., the predominant alkaloid in tobacco, has be-\nglass imptant with a Silastic® cap through which nicotine is\ncomc a w idely studied drug for its pharmacological and toxi-\ncological effects. It may induce on exacerbate several car-\nslowly released.\ndioyavcular, respiratory. and neoplastic states in both hu-\nMETHOD\nmans and laboratory animals [7. 8, 10].\nMuterials\ntion of cigarette smoke or bccally through th lining of te\nIn humans. nicotine is normally administered by inhala-\nThe dirug and chemical sources were as follows: nicotine\nmouth by absorption of solubilized nicotine from chewing\nalkaloid. Sigma Chemical Co. (St. Louis. MOn: Silastic\ntobacco. Blood nicotine levels ofen remain high as the result\nelastomer. 382 Medical Grade Elastomer mixcdi with\nof chain-smoking or the continual chewing of tobacco. In\nanimals. forced-administration methods for nicotine include\ncatalyst. Catalyst M Stannous Octoate, Dow Comning Co.\nparenieral injection [13-16]. administration by inhalation of\n(Midland. Mli: N-ethy luornicotine, a gift from Dr. P. Jacobs,\nUniversity of California at San Francisco.\nigarctte smoe 13. solbilization n drinking water 14) and\ninjection in singic doses [2) or chronically via Alzet\nAnimaly\nminipump (1) into thc ventricles of the brain. Nicotine has\nalso been self-administered intravenously [17). The most\nSixteein female SD/ARC rats (derived from Sprague Daw-\ncomon route of forcedadministration in anmals is by par\nThe University of Texas) were used in the experiments.\nley stock. originally obtained from Chartes River and bred at\nenteral injectin. Ofentimes upto 6 daiy doses are given.\nThey were housed in groups of 3-4 in wire bottomed stain-\nthe duration of each dose being 15-120 minutes, depending\nless steel cages on  1/12 gh/dar cycle a Food (Lab\nupon the size of the dose [9.13].\nPrevious animal studies involving tolerance to nicotine or\nBlox. Purinad and water were available ad lib. The rats\nto the toxicological effects of continual exposure to nicotine\nweighed 200 250 g at the start of the experiment.\nhave been hampered by the inubility of investigators to ad.\nImplan Marudacture\nminuster nicotine conveniently over long periods of time. We\nfelt that a sustained-release form of nicotine would be useful.\nPreliminary (unpublished; results in our laboratory indi-\nin much the same manner as sustained release forms for\ncated that the sod nicotine biartrate dd not rele easly\nmorphine [11]. ethanol (5.6], and amphetamine [4] have been\nuseful for studying chronic toxicity and dependence in\nfrom a silaistic matix such s the one used for morphine 11.\nTherefore, we chove the liquid nicotine alkaloid for our re-\nanimals. This paper reports the sticcessful development of a\nleave studics. In further tests we found that the release of\nThe wor wasppedrant  1 from The Couc for Toba RevechU.S.A. Inc Ponis of t wore porein\n1.JnP.= 39: 316. 1980\nSend reprnt requests toc Carlton K. Enckson. College of Pharmacs. The Universaty of Tevas. Austin, TX 78712.\nCopyright · 1982 ANKHO International Inc.--0091-3057:82/080183-03503.00/0"
}